Suppression of apoptosis and clonogenic survival in irradiated human lymphoblasts with different TP53 status

Radiation Research

Volumn 158, Issue 6, 2002, Pages 699-706

  Schäfer, Jörg ^a   Bachtler, Jens ^a   Engling, Andre ^a   Little, John B ^b   Weber, Klaus Josef ^a,c   Wenz, Frederik ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c Labor Strahlenbiologie   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CAFFEINE; CASPASE; CELL PROTEIN; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN P53; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL CYCLE G2 PHASE; CELL LINE; CELL SURVIVAL; CHROMOSOME DAMAGE; CLONOGENESIS; CONTROLLED STUDY; DNA DETERMINATION; DNA REPAIR; DNA STRAND BREAKAGE; ENZYME INHIBITION; HUMAN; HUMAN CELL; LYMPHOBLAST; MITOSIS; PRIORITY JOURNAL; PROTEIN FUNCTION; RADIATION INJURY; RADIOSENSITIVITY;

EID: 0036896782     PISSN: 00337587     EISSN: None     Source Type: Journal    
DOI: 10.1667/0033-7587(2002)158[0699:SOAACS]2.0.CO;2     Document Type: Article

References (50)

1. P. L. Olive and R. E. Durand, Apoptosis: An indicator of radiosensitivity in vitro? Int. J. Radiat. Biol. 71, 695-707 (1997).
2. J. H. Hendry and C. M. West, Apoptosis and mitotic cell death: Their relative contributions to normal-tissue and tumour radiation response. Int. J. Radiat. Biol. 71, 709-719 (1997).
3. J. M. Brown and B. G. Wouters, Apoptosis, p53, and tumor cell sensitivity to anticancer agents. Cancer Res. 59, 1391-1399 (1999).
4. E. Cohen-Jonathan, E. J. Bernhard and W. G. McKenna, How does radiation kill cells? Curr. Opin. Chem. Biol. 3, 77-83 (1999).
5. S. W. Lowe, H. E. Ruley, T. Jacks and D. E. Housman, p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell 74, 957-967 (1993).
6. I. R. Radford, p53 status, DNA double-strand break repair proficiency, and radiation response of mouse lymphoid and myeloid cell lines. Int. J. Radiat. Biol. 66, 557-560 (1994).
7. I. R. Radford and T. K. Murphy, Radiation response of mouse lymphoid and myeloid cell lines. Part III. Different signals can lead to apoptosis and may influence sensitivity to killing by DNA doublestrand breakage. Int. J. Radiat. Biol. 65, 229-239 (1994).
8. D. J. Allan, Radiation-induced apoptosis: Its role in a MADCaT (mitosis-apoptosis-differentiation-calcium toxicity) scheme of cytotoxicity mechanisms. Int. J. Radiat. Biol. 62, 145-152 (1992).
9. R. E. Meyn, L. C. Stephens, D. W. Voehringer, M. D. Story, N. Mirkovic and L. Milas, Biochemical modulation of radiation-induced apoptosis in murine lymphoma cells. Radiat. Res. 136, 327-334 (1993).
10. M. Hollstein, D. Sidransky, B. Vogelstein and C. C. Harris, p53 mutations in human cancers. Science 253, 49-53 (1991).
11. W. C. Dewey, C. C. Ling and R. E. Meyn, Radiation-induced apoptosis: Relevance to radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 33, 781-796 (1995).
12. D. R. Aldridge and I. R. Radford, Explaining differences in sensitivity to killing by ionizing radiation between human lymphoid cell lines. Cancer Res. 58, 2817-2824 (1998).
13. J. S. Bedford, J. B. Mitchell, H. G. Griggs and M. A. Bender, Radiation-induced cellular reproductive death and chromosome aberrations. Radiat. Res. 76, 573-586 (1978).
14. P. L. Olive, The role of DNA single- and double-strand breaks in cell killing by ionizing radiation. Radiat. Res. 150 (Suppl.), S42-S51 (1998).
15. K. J. Weber and F. Wenz, P53, apoptosis and radiosensitivity - Experimental and clinical data. Onkologie 25, 136-141 (2002).
16. J. A. Levy, M. Virolainen and V. Defendi, Human lymphoblastoid lines from lymph node and spleen. Cancer 22, 517-524 (1968).
17. M. B. Benjamin, H. Potter, D. W. Yandell and J. B. Little, A system for assaying homologous recombination at the endogenous human thymidine kinase gene. Proc. Natl. Acad. Sci. USA 88, 6652-6656 (1991).
18. 1 arrest in two closely related human lymphoblast cell lines that differ in p53 status. J. Biol. Chem. 270, 11033-11036 (1995).
19. Y. Yu, C. Y. Li and J. B. Little, Abrogation of p53 function by HPV16 E6 gene delays apoptosis and enhances mutagenesis but does not alter radiosensitivity in TK6 human lymphoblast cells. Oncogene 14, 1661-1667 (1997).
20. M. Scheffner, B. A. Werness, J. M. Huibregtse, A. J. Levine and P M. Howley. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 63, 1129-1136 (1990).
21. F. Wenz, Y. Yu, H. Nagasawa, A. C. Imrich, P. Keng and J. B. Little, Lack of uncoupling of S phase and mitosis after irradiation in p53-human lymphoblast cell lines. Radiat. Res. 148, 129-134 (1997).
22. J. L. Schwartz, R. Jordan, B. A. Sedita, M. J. Swenningson, J. P. Banath and P. L. Olive, Different sensitivity to cell killing and chromosome mutation induction by gamma rays in two human lymphoblastoid cell lines derived from a single donor: Possible role of apoptosis. Mutagenesis 10, 227-233 (1995).
23. P. L. Olive, G. Frazer and J. P. Banath, Radiation-induced apoptosis measured in TK6 human B lymphoblast cells using the comet assay. Radiat. Res. 136, 130-136 (1993).
24. W. Zhen, C. M. Denault, K. Loviscek, S. Walter, L. Geng and A. T. Vaughan, The relative radiosensitivity of TK6 and WI-L2-NS lymphoblastoid cells derived from a common source is primarily determined by their p53 mutational status. Mutat. Res. 346, 85-92 (1995).
25. J. L. Schwartz and R. Jordan, Selective elimination of human lymphoid cells with unstable chromosome aberrations by p53-dependent apoptosis. Carcinogenesis 18, 201-205 (1997).
26. Y. Yu and J. B. Little, p53 is involved in but not required for ionizing radiation-induced caspase-3 activation and apoptosis in human lymphoblast cell lines. Cancer Res. 58, 4277-4281 (1998).
27. F. Wenz, E. I. Azzam and J. B. Little, The response of proliferating cell nuclear antigen to ionizing radiation in human lymphoblastoid cell lines is dependent on p53. Radiat. Res. 149, 32-40 (1998).
28. I. Nicoletti, G. Migliorati, M. C. Pagliacci, F. Grignani and C. Riccardi, A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J. Immunol. Methods 139, 271-279 (1991).
29. N. P. Singh, M. T. McCoy, R. R. Tice and E. L. Schneider, A simple technique for quantitation of low levels of DNA damage in individual cells. Exp. Cell Res. 175, 184-191 (1988).
30. 2 histography in R3327-AT rodent tumors. Radiat. Res. 154, 439-446 (2000).
31. C. R. Kent, J. J. Eady, G. M. Ross and G. G. Steel, The comet moment as a measure of DNA damage in the comet assay. Int. J. Radiat. Biol. 67, 655-660 (1995).
32. K. J. Weber and M. Flentje, Lethality of heavy ion-induced DNA double-strand breaks in mammalian cells. Int. J. Radiat. Biol. 64, 169-178 (1993).
33. V. Rudat, N. Bachmann, J-H. Kuepper and K. J. Weber, Overexpression of the DNA-binding domain of poly(ADP-ribose)polymerase inhibits rejoining of ionizing radiation-induced DNA double-strand breaks. Int. J. Radiat. Biol. 77, 303-307 (2001).
34. K. Butz, N. Whitaker, C. Denk, A. Ullmann, C. Geisen and F. HoppeSeyler, Induction of the p53-target gene GADD45 in HPV-positive cancer cells. Oncogene 18, 2381-2386 (1999).
35. D. Dittmer, S. Pati, G. Zambetti, S. Chu, A. K. Teresky, M. Moore, C. Finlay and A. J. Levine, Gain of function mutations in p53. Nat. Genet. 4, 42-46 (1993).
36. A. Sigal and V. Rotter, Oncogenic mutations of the p53 tumor suppressor: The demons of the guardian of the genome. Cancer Res. 60, 6788-6793 (2000).
37. R. W. Johnstone, A. A. Ruefli and M. J. Smyth, Multiple physiological functions for multidrug transporter P-glycoprotein? Trends Biochem. Sci. 25, 1-6 (2000).
38. A. C. Ruth and I. G. Roninson, Effects of the multidrug transporter p-glycoprotein on cellular response to ionizing radiation. Cancer Res. 60, 2576-2578 (2000).
39. K. J. Weber, A. Engling, J. Schaefer, S. Fruehauf and F. Wenz, Genetherapeutic and pharmacological suppression of radiation-induced apoptosis. Int. J. Radiat. Oncol. Biol. Phys. 48 (Suppl. 1), 279 (2000). [abstract]
40. C. Geiger, K. J. Weber and F. Wenz, Radiation induced chromosome aberrations and clonogenic survival in human lymphoblastoid cell lines with different p53 status. Strahlenther. Onkol. 175, 289-292 (1999).
41. R. Y. Poon, M. S. Chau, K. Yamashita and T. Hunter, The role of Cdc2 feedback loop control in the DNA damage checkpoint in mammalian cells. Cancer Res. 57, 5168-5178 (1997).
42. A. Blasina, B. D. Price, G. A. Turenne and C. H. McGowan, Caffeine inhibits the checkpoint kinase ATM. Curr. Biol. 9, 1135-1138 (1999).
43. 2/M DNA damage checkpoint by inhibiting ataxia-telangiectasia-mutated kinase activity. J. Biol. Chem. 275, 10342-10348 (2000).
44. 2 delay causes HeLa cells to undergo apoptosis instead of mitotic death. Int. J. Radiat. Biol. 69, 575-584 (1996).
45. W. Zhen and A. T. Vaughan, Effect of caffeine on radiation-induced apoptosis in TK6 cells. Radiat. Res. 141, 170-175 (1995).
46. A. Hirao, Y-Y. Kong, S. Matsuoka, A. Wakeham, J. Ruland, H. Yoshida, D. Liu, S. J. Elledge and T. W. Mak, DNA damage-induced activation of p53 by the checkpoint kinase Chk2. Science 287, 1824-1827 (2000).
47. 1 arrest but is required for a latent p53-mediated apoptotic response. Proc. Natl. Acad. Sci. USA 99, 9825-9829 (2002).
48. 2 delay. Cancer Res. 55, 1643-1648 (1995).
49. F. Xia and H. L. Liber, The tumor suppressor p53 modifies mutational processes in a human lymphoblastoid cell line. Mutat. Res. 373, 87-97 (1997).
50. J. L. Schwartz, R. Jordan, H. Liber, J. P. Murnane and H. H. Evans, TP53-dependent chromosome instability is associated with transient reductions in telomere length in immortal telomerase-positive cell lines. Genes Chromosomes Cancer 30, 236-244 (2001).